FR2775983B1 - Milieu et procede de propagation et de multiplication virales - Google Patents

Milieu et procede de propagation et de multiplication virales

Info

Publication number
FR2775983B1
FR2775983B1 FR9803333A FR9803333A FR2775983B1 FR 2775983 B1 FR2775983 B1 FR 2775983B1 FR 9803333 A FR9803333 A FR 9803333A FR 9803333 A FR9803333 A FR 9803333A FR 2775983 B1 FR2775983 B1 FR 2775983B1
Authority
FR
France
Prior art keywords
viral propagation
multiplication medium
multiplication
medium
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9803333A
Other languages
English (en)
Other versions
FR2775983A1 (fr
Inventor
Pierre Heimindinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur SA
Original Assignee
Pasteur Merieux Serum et Vaccines SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9803333A priority Critical patent/FR2775983B1/fr
Application filed by Pasteur Merieux Serum et Vaccines SA filed Critical Pasteur Merieux Serum et Vaccines SA
Priority to NZ506872A priority patent/NZ506872A/en
Priority to IL13825099A priority patent/IL138250A0/xx
Priority to CN99803965A priority patent/CN1301297A/zh
Priority to TR200002641T priority patent/TR200002641T2/xx
Priority to EA200000934A priority patent/EA200000934A1/ru
Priority to EP99907713A priority patent/EP1062324A2/fr
Priority to CA 2322619 priority patent/CA2322619A1/fr
Priority to KR1020007010026A priority patent/KR20010072556A/ko
Priority to AU27352/99A priority patent/AU752577B2/en
Priority to SK1288-2000A priority patent/SK12882000A3/sk
Priority to PCT/FR1999/000578 priority patent/WO1999047648A2/fr
Priority to PL34355799A priority patent/PL343557A1/xx
Priority to HU0101081A priority patent/HUP0101081A3/hu
Priority to JP2000536831A priority patent/JP2002506636A/ja
Priority to BR9908744A priority patent/BR9908744A/pt
Publication of FR2775983A1 publication Critical patent/FR2775983A1/fr
Application granted granted Critical
Publication of FR2775983B1 publication Critical patent/FR2775983B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0043—Medium free of human- or animal-derived components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/76—Undefined extracts from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32651—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
FR9803333A 1998-03-13 1998-03-13 Milieu et procede de propagation et de multiplication virales Expired - Fee Related FR2775983B1 (fr)

Priority Applications (16)

Application Number Priority Date Filing Date Title
FR9803333A FR2775983B1 (fr) 1998-03-13 1998-03-13 Milieu et procede de propagation et de multiplication virales
SK1288-2000A SK12882000A3 (sk) 1998-03-13 1999-03-15 Médium a spôsob na propagáciu a multiplikáciu vírusov
CN99803965A CN1301297A (zh) 1998-03-13 1999-03-15 用于病毒繁殖和增殖的培养基和方法
TR200002641T TR200002641T2 (tr) 1998-03-13 1999-03-15 Viral yayılma ve çoğalma için ortam ve yöntem
EA200000934A EA200000934A1 (ru) 1998-03-13 1999-03-15 Среда и способ осуществления роста и размножения вирусов
EP99907713A EP1062324A2 (fr) 1998-03-13 1999-03-15 Milieu et procede de propagation et de multiplication virales
CA 2322619 CA2322619A1 (fr) 1998-03-13 1999-03-15 Milieu et procede de propagation et de multiplication virales
KR1020007010026A KR20010072556A (ko) 1998-03-13 1999-03-15 바이러스의 증식 및 생육을 위한 배지 및 이를 위한 방법
NZ506872A NZ506872A (en) 1998-03-13 1999-03-15 Medium and method for viral propagation and growth
IL13825099A IL138250A0 (en) 1998-03-13 1999-03-15 Medium and method for viral propagation and growth
PCT/FR1999/000578 WO1999047648A2 (fr) 1998-03-13 1999-03-15 Milieu et procede de propagation et de multiplication virales
PL34355799A PL343557A1 (en) 1998-03-13 1999-03-15 Medium and method for viral propagation and growth
HU0101081A HUP0101081A3 (en) 1998-03-13 1999-03-15 Medium and method for viral propagation and growth
JP2000536831A JP2002506636A (ja) 1998-03-13 1999-03-15 ウイルスの伝播および増殖用の培地および方法
BR9908744A BR9908744A (pt) 1998-03-13 1999-03-15 Uso de um meio de cultura
AU27352/99A AU752577B2 (en) 1998-03-13 1999-03-15 Medium and method for viral propagation and growth

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9803333A FR2775983B1 (fr) 1998-03-13 1998-03-13 Milieu et procede de propagation et de multiplication virales

Publications (2)

Publication Number Publication Date
FR2775983A1 FR2775983A1 (fr) 1999-09-17
FR2775983B1 true FR2775983B1 (fr) 2000-11-10

Family

ID=9524203

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9803333A Expired - Fee Related FR2775983B1 (fr) 1998-03-13 1998-03-13 Milieu et procede de propagation et de multiplication virales

Country Status (16)

Country Link
EP (1) EP1062324A2 (fr)
JP (1) JP2002506636A (fr)
KR (1) KR20010072556A (fr)
CN (1) CN1301297A (fr)
AU (1) AU752577B2 (fr)
BR (1) BR9908744A (fr)
CA (1) CA2322619A1 (fr)
EA (1) EA200000934A1 (fr)
FR (1) FR2775983B1 (fr)
HU (1) HUP0101081A3 (fr)
IL (1) IL138250A0 (fr)
NZ (1) NZ506872A (fr)
PL (1) PL343557A1 (fr)
SK (1) SK12882000A3 (fr)
TR (1) TR200002641T2 (fr)
WO (1) WO1999047648A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000083657A (ja) * 1998-07-13 2000-03-28 Chemo Sero Therapeut Res Inst 日本脳炎ウイルスワクチン
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
ES2328466T3 (es) * 2001-03-27 2009-11-13 Vertex Pharmaceuticals Incorporated Composiciones y metodos utiles para la infeccion por hcv.
JP2005532057A (ja) * 2002-07-09 2005-10-27 バクスター・インターナショナル・インコーポレイテッド 細胞を培養するための動物性タンパク質非含有培地
GB0304799D0 (en) 2003-03-03 2003-04-09 Glaxosmithkline Biolog Sa Novel method
US20060094104A1 (en) 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
EP2522717B1 (fr) 2006-01-04 2014-04-02 Baxter International Inc Milieux de culture cellulaire sans oligopeptides
JP5458536B2 (ja) * 2008-09-17 2014-04-02 不二製油株式会社 乳酸の製造方法及び乳酸発酵用添加剤
CN107043739A (zh) * 2017-04-24 2017-08-15 浙江美保龙生物技术有限公司 一种Vero细胞培养液添加剂及其制备方法、使用方法
CN107129963A (zh) * 2017-04-24 2017-09-05 浙江美保龙生物技术有限公司 一种df‑1细胞培养液添加剂及其制备方法、使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498537A (en) * 1994-03-09 1996-03-12 Cellco, Inc. Serum-free production of packaged viral vector
FR2732347A1 (fr) * 1995-03-30 1996-10-04 Bio Media Extrait vegetal, son procede de preparation et ses applications en medecine humaine ou veterinaire
CA2258501C (fr) * 1997-04-16 2004-01-20 Feva N.V. Extrait vegetal, procede de preparation associe, et utilisations en medecine humaine et veterinaire

Also Published As

Publication number Publication date
JP2002506636A (ja) 2002-03-05
FR2775983A1 (fr) 1999-09-17
BR9908744A (pt) 2000-12-26
TR200002641T2 (tr) 2000-11-21
WO1999047648A2 (fr) 1999-09-23
IL138250A0 (en) 2001-10-31
PL343557A1 (en) 2001-08-27
CA2322619A1 (fr) 1999-09-23
AU752577B2 (en) 2002-09-26
CN1301297A (zh) 2001-06-27
SK12882000A3 (sk) 2001-05-10
HUP0101081A3 (en) 2003-04-28
EP1062324A2 (fr) 2000-12-27
KR20010072556A (ko) 2001-07-31
AU2735299A (en) 1999-10-11
NZ506872A (en) 2002-03-01
HUP0101081A2 (hu) 2001-07-30
EA200000934A1 (ru) 2001-02-26
WO1999047648A3 (fr) 1999-11-04

Similar Documents

Publication Publication Date Title
NL194776B (nl) Plantenvermeerderingsinrichting en werkwijze.
NO20011303L (no) Fremgangsmåter for nukleinsyreoppformering og sekvensering
DK0870361T3 (da) Effektiv effektforstærker med parallelle trin
ID23485A (id) Kerangka lembaran berjangkar dan sublantai
DK1105123T3 (da) Farmaceutiske præparater indeholdende lipase-inhibitorer og chitosan
NO985278L (no) Elektromagnetiske-til-akustiske og akustiske-til-elektro-magnetiske forsterkere og fremgangsmÕter for bruk av disse
FI982435A0 (fi) Lineaarinen tehovahvistinjärjestely ja menetelmä sen käyttämiseksi
DE69930780D1 (de) Leistungsverstärker
DE59901655D1 (de) Laserverstärkersystem
DE69931543D1 (de) Leistungsverstärker
DE69821408D1 (de) Multiplikationsverfahren und -vorrichtung
FR2782656B1 (fr) Distributeur-melangeur-extracteur de fluides et procede associe
DE69620099T2 (de) Hochfrequenz-Leistungsverstärker
DE59903605D1 (de) Laserverstärkersystem
FR2775983B1 (fr) Milieu et procede de propagation et de multiplication virales
DE59806475D1 (de) Urokinase-inhibitoren
DE69924047D1 (de) Flüssigkeitsausstossverfahren
NO20003164L (no) Ultralydmetode
DE69808362D1 (de) Multiplizierverfahren und Multiplizierschaltung
DE59610683D1 (de) Laser mit Frequenzvervielfachung
DE69406108T2 (de) Niederfrequenzverstärker
DE69800596T2 (de) Phyllokaktusvermehrungsverfahren
NO961749L (no) Forbedret celledyrkningsfremgangsmåte og -medium
DE69903035D1 (de) Erwärmungsverfahren
ID22243A (id) Amplifier penguatan tinggi

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name
ST Notification of lapse